FI20021762A0 - Nya terapeutiska ämnen och preparat - Google Patents
Nya terapeutiska ämnen och preparatInfo
- Publication number
- FI20021762A0 FI20021762A0 FI20021762A FI20021762A FI20021762A0 FI 20021762 A0 FI20021762 A0 FI 20021762A0 FI 20021762 A FI20021762 A FI 20021762A FI 20021762 A FI20021762 A FI 20021762A FI 20021762 A0 FI20021762 A0 FI 20021762A0
- Authority
- FI
- Finland
- Prior art keywords
- preparations
- new therapeutic
- therapeutic substances
- substances
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20021762A FI20021762A0 (sv) | 2002-10-03 | 2002-10-03 | Nya terapeutiska ämnen och preparat |
AU2003267476A AU2003267476A1 (en) | 2002-10-03 | 2003-10-03 | Tumor targeting agents and uses thereof |
EP03748163A EP1549669A1 (en) | 2002-10-03 | 2003-10-03 | Tumor targeting agents and uses thereof |
US10/530,024 US20060275213A1 (en) | 2002-10-03 | 2003-10-03 | Tumor targeting agents and uses thereof |
CA002500833A CA2500833A1 (en) | 2002-10-03 | 2003-10-03 | Tumor targeting agents and uses thereof |
CNA2003801048277A CN1720258A (zh) | 2002-10-03 | 2003-10-03 | 肿瘤靶向剂及其应用 |
JP2004540845A JP2006517907A (ja) | 2002-10-03 | 2003-10-03 | 腫瘍標的化剤及びその使用 |
PCT/FI2003/000726 WO2004031221A1 (en) | 2002-10-03 | 2003-10-03 | Tumor targeting agents and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20021762A FI20021762A0 (sv) | 2002-10-03 | 2002-10-03 | Nya terapeutiska ämnen och preparat |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20021762A0 true FI20021762A0 (sv) | 2002-10-03 |
Family
ID=8564695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20021762A FI20021762A0 (sv) | 2002-10-03 | 2002-10-03 | Nya terapeutiska ämnen och preparat |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060275213A1 (sv) |
EP (1) | EP1549669A1 (sv) |
JP (1) | JP2006517907A (sv) |
CN (1) | CN1720258A (sv) |
AU (1) | AU2003267476A1 (sv) |
CA (1) | CA2500833A1 (sv) |
FI (1) | FI20021762A0 (sv) |
WO (1) | WO2004031221A1 (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130202652A1 (en) * | 2010-07-30 | 2013-08-08 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for delivery of active agents |
WO2016172187A1 (en) * | 2015-04-20 | 2016-10-27 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Methods and compositions related to kras inhibitors |
US11278521B2 (en) | 2015-12-15 | 2022-03-22 | University Of South Florida | GAS5 binding compounds, formulations, and uses thereof |
CN107987127B (zh) * | 2017-06-08 | 2020-09-15 | 中山大学附属肿瘤医院 | 整合素α6靶向多肽及应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0271041A3 (en) * | 1986-12-10 | 1990-04-11 | Abbott Laboratories | Atrial peptide derivatives |
US5981478A (en) * | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
EP1961760A3 (en) * | 1995-06-07 | 2008-09-03 | Glaxo Group Limited | Peptides and compounds that bind to a thrombopoietin receptor |
US5622699A (en) * | 1995-09-11 | 1997-04-22 | La Jolla Cancer Research Foundation | Method of identifying molecules that home to a selected organ in vivo |
US7452963B2 (en) * | 2001-03-27 | 2008-11-18 | Samuel Bogoch | Replikin peptides and antibodies therefore |
-
2002
- 2002-10-03 FI FI20021762A patent/FI20021762A0/sv unknown
-
2003
- 2003-10-03 EP EP03748163A patent/EP1549669A1/en not_active Withdrawn
- 2003-10-03 AU AU2003267476A patent/AU2003267476A1/en not_active Abandoned
- 2003-10-03 WO PCT/FI2003/000726 patent/WO2004031221A1/en active Application Filing
- 2003-10-03 JP JP2004540845A patent/JP2006517907A/ja not_active Abandoned
- 2003-10-03 CA CA002500833A patent/CA2500833A1/en not_active Abandoned
- 2003-10-03 CN CNA2003801048277A patent/CN1720258A/zh active Pending
- 2003-10-03 US US10/530,024 patent/US20060275213A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004031221A1 (en) | 2004-04-15 |
US20060275213A1 (en) | 2006-12-07 |
AU2003267476A1 (en) | 2004-04-23 |
EP1549669A1 (en) | 2005-07-06 |
WO2004031221A9 (en) | 2004-07-08 |
CN1720258A (zh) | 2006-01-11 |
CA2500833A1 (en) | 2004-04-15 |
JP2006517907A (ja) | 2006-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20033556D0 (no) | Farmasöytiske preparater | |
PT1501534E (pt) | Formulacoes farmaceuticas | |
HK1164133A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
ATE480567T1 (de) | Hochkonzentrierter antikörper und proteinformulierungen | |
SE0203190L (sv) | Anordning och förfarande | |
NO20044192L (no) | 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater | |
NO20055652D0 (no) | Laktatinneholdende farmasoytisk preparat og anvendelse av dette | |
HK1091727A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
IS7571A (is) | Ný lífeðlisfræðilega virk efni | |
IS7715A (is) | Nýjar lyfjasamsetningar úr módafíníl | |
IS7798A (is) | Efnasambönd, lyfjablöndur og aðferðir | |
NO20044916L (no) | Preparater av sulfinylacetamid | |
NO20050689L (no) | Terapeutisk anvendelse | |
SE0301997L (sv) | Anordning och förfarande | |
NO20043576L (no) | Pharmaceutical formulation comprising melatonin | |
PT1178981E (pt) | 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos | |
FI20021762A0 (sv) | Nya terapeutiska ämnen och preparat | |
FI20021617A0 (sv) | Diagnostiska och terapeutiska förfaranden | |
FI20031927A0 (sv) | Terapeutiskt verksamma ämnen och deras användning | |
FI20021763A0 (sv) | Nya terapeutiskt aktiva ämnen och deras användning | |
FI20021760A0 (sv) | Nya terapeutiska/diagnostiska ämnen och preparat samt deras tillämpningar | |
FI20030871A0 (sv) | Terapeutiskt aktiva ämnen och deras användning | |
FI20021761A0 (sv) | Nya läkemedel och läkemedelspreparat samt deras användning | |
FI20031920A0 (sv) | Nya radioläkemedel och diagnostiska beredningar | |
FI20031797A (sv) | Nya radioläkemedel och diagnostiska beredningar |